摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-Nitro-phenyl)-brenztraubensaeure | 38712-57-1

中文名称
——
中文别名
——
英文名称
(3-Nitro-phenyl)-brenztraubensaeure
英文别名
3-(3-nitro-phenyl)-2-oxo-propionic acid;3-(3-nitrophenyl)-2-oxopropanoic acid
(3-Nitro-phenyl)-brenztraubensaeure化学式
CAS
38712-57-1
化学式
C9H7NO5
mdl
——
分子量
209.158
InChiKey
JTJJIPVJAFWSBS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    180 °C(Solv: water (7732-18-5); acetic acid (64-19-7))
  • 沸点:
    406.6±28.0 °C(Predicted)
  • 密度:
    1.469±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    100
  • 氢给体数:
    1
  • 氢受体数:
    5

SDS

SDS:c41df7dc1738e827c8de54b1eba1c8e5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3-Nitro-phenyl)-brenztraubensaeuresodium hydroxide 、 sodium tetrahydroborate 作用下, 以79%的产率得到2-hydroxy-3-(3-nitrophenyl)propionic acid
    参考文献:
    名称:
    Deracemisation of aryl substituted α-hydroxy esters using Candida parapsilosis ATCC 7330: effect of substrate structure and mechanism
    摘要:
    Candida parapsilosis ATCC 7330 was found to be an efficient biocatalyst for the deracemisation of aryl alpha-hydroxy esters (65-85% yield and 90-99% ee). A variety of aryl and aryl substituted alpha-hydroxy esters were synthesized to reflect steric and electronic effects on biocatalytic deracemisation. The mechanism of this biocatalytic deracemisation was found to be stereoinversion. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2005.09.104
  • 作为产物:
    描述:
    5-(3-nitro-benzylidene)-2-thioxo-oxazolidin-4-one 在 sodium hydroxide 作用下, 生成 (3-Nitro-phenyl)-brenztraubensaeure
    参考文献:
    名称:
    Gorisdra; Baranow, Zhurnal Obshchei Khimii, 1956, vol. 26, p. 3092,3095; engl. Ausg. S. 3443, 3445
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Engineered Aminotransferase for the Production of<scp>d</scp>-Phenylalanine Derivatives Using Biocatalytic Cascades
    作者:Curtis J. W. Walton、Fabio Parmeggiani、Janet E. B. Barber、Jenna L. McCann、Nicholas J. Turner、Roberto A. Chica
    DOI:10.1002/cctc.201701068
    日期:2018.1.23
    commercially available racemic mixtures or l‐amino acids. These whole‐cell systems couple Proteus mirabilis l‐amino acid deaminase with an engineered aminotransferase that displays native‐like activity towards dphenylalanine, which we generated from Bacillus sp. YM‐1 d‐amino acid aminotransferase. Our cascades are applicable to preparative‐scale synthesis and do not require cofactor‐regeneration systems
    d-苯丙氨酸衍生物是多种药物的重要手性构件。在这里,我们开发了立体反转和脱硫生物催化级联反应,以合成d-苯丙氨酸衍生物,这些衍生物含有苯胺环上不同大小的给电子或吸电子取代基,且苯环上不同位置的对映体过量(从90%到> 99%ee很高)可用的外消旋混合物或l-氨基酸。这些全细胞系统将奇异变形杆菌 l-氨基酸脱氨酶与工程化的氨基转移酶结合,该酶对我们从芽孢杆菌属中产生的对d-苯丙氨酸表现出天然的活性。YM-1d-氨基酸氨基转移酶。我们的级联适用于制备规模的合成,不需要辅因子再生系统或化学还原剂。
  • Synthesis of<scp>D</scp>- and<scp>L</scp>-Phenylalanine Derivatives by Phenylalanine Ammonia Lyases: A Multienzymatic Cascade Process
    作者:Fabio Parmeggiani、Sarah L. Lovelock、Nicholas J. Weise、Syed T. Ahmed、Nicholas J. Turner
    DOI:10.1002/anie.201410670
    日期:2015.4.7
    phenylalanine ammonia lyase (PAL) amination with a chemoenzymatic deracemization (based on stereoselective oxidation and nonselective reduction). A simple high‐throughput solid‐phase screening method has also been developed to identify PALs with higher rates of formation of non‐natural D‐phenylalanines. The best variants were exploited in the chemoenzymatic cascade, thus increasing the yield and ee value
    通过将苯丙氨酸解氨酶 (PAL) 胺化与化学酶脱外消旋(基于立体选择性氧化和非选择性还原)。还开发了一种简单的高通量固相筛选方法来鉴定具有较高非天然D-苯丙氨酸形成率的 PAL。在化学酶级联中利用了最佳变体,从而提高了D配置产品的产量和 ee 值。此外,该系统还扩展到制备低浓度的L-苯丙氨酸。ee 值使用PAL胺化。
  • Compounds for the Inhibition of Cellular Proliferation
    申请人:Chorev Michael
    公开号:US20130178505A1
    公开(公告)日:2013-07-11
    Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.
    提供了抑制翻译的组合物和方法。本文披露的化合物可用于治疗以下疾病:(1)细胞增殖性疾病,(2)非增殖性退行性疾病,(3)病毒感染,(4)与病毒感染有关的疾病,以及(5)非增殖性代谢性疾病,如II型糖尿病,其中抑制翻译起始有益。本文还提供了用于治疗上述疾病的方法和试剂盒。
  • Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
    作者:Matthias G. J. Baud、Thomas Leiser、Patricia Haus、Sharon Samlal、Ai Ching Wong、Robert J. Wood、Vanessa Petrucci、Mekala Gunaratnam、Siobhan M. Hughes、Lakjaya Buluwela、Fabrice Turlais、Stephen Neidle、Franz-Josef Meyer-Almes、Andrew J. P. White、Matthew J. Fuchter
    DOI:10.1021/jm2016182
    日期:2012.2.23
    Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC50 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotcodcity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.
  • [EN] COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION<br/>[FR] COMPOSÉS POUR INHIBER LA PROLIFÉRATION CELLULAIRE
    申请人:HARVARD COLLEGE
    公开号:WO2012006068A3
    公开(公告)日:2013-05-10
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐